$107.35 +1.16 (%) Johnson & Johnson - NYSE

Sep. 18, 2014 | 04:00 PM

Partner Headlines

  1. New Active ETF for All Risk Environments

    Benzinga | Sep. 17, 2014 | 10:05AM EST
  2. 3 Companies Investing In Stem Cell Research

    Benzinga | Sep. 14, 2014 | 16:34PM EST
  3. Addressing Disengagement And Depression Lifts Workers

    IBD | Sep. 12, 2014 | 14:41PM EST
  4. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD | Sep. 11, 2014 | 17:41PM EST
  5. Steadier, Better: 35 Years Of Low-Volatility Stocks

    YCharts | Sep. 8, 2014 | 20:54PM EST
  6. Johnson & Johnson Metal Hip Might Lead To Poisoning, Facing 6,000+ Suits

    Benzinga | Sep. 4, 2014 | 17:16PM EST
  7. US Stock Futures Gain; ADP, Jobless Claims Data In Focus

    Benzinga | Sep. 4, 2014 | 07:35AM EST
  8. Sharper Focus Pays Dividends At Johnson & Johnson

    IBD | Sep. 3, 2014 | 16:29PM EST
  9. Drug M&A Boom Driven By Long-Term Trends: PwC

    IBD | Sep. 3, 2014 | 16:22PM EST
  10. Infinity Pharma Joins AbbVie On Blood Cancer Drug

    IBD | Sep. 3, 2014 | 13:20PM EST
  11. Morgan Stanley Sees Johnson & Johnson Taking Rx Estimates Higher

    Benzinga | Sep. 2, 2014 | 09:10AM EST
  12. U.S., U.K. ISIS Response Differ Widely

    FoxBusiness | Aug. 29, 2014 | 11:34AM EST
  13. Bank Of America Remains Optimistic On Johnson & Johnson

    Benzinga | Aug. 29, 2014 | 09:13AM EST
  14. Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson

    Benzinga | Aug. 29, 2014 | 08:47AM EST
  15. Focus On A Big-Picture Purpose To Get Top Results

    IBD | Aug. 28, 2014 | 13:18PM EST
  16. Think Like An Owner

    GuruFocus | Aug. 27, 2014 | 17:07PM EST
  17. Late-Cycle Nirvana: Moaty Dividends on the Cheap

    YCharts | Aug. 25, 2014 | 23:48PM EST
  18. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga | Aug. 25, 2014 | 16:03PM EST
  19. Here's Why Johnson & Johnson Is a Good Investment at 52-Week Highs

    GuruFocus | Aug. 25, 2014 | 12:57PM EST
  20. Omnicom Offers Steady Profit Growth, Rising Dividend

    IBD | Aug. 22, 2014 | 17:25PM EST
  21. #PreMarket Primer: Friday, August 22: Draghi, Yellen Set To Speak At Jackson Hole

    Benzinga | Aug. 22, 2014 | 07:07AM EST
  22. Illumina lines up key partners

    IBD | Aug. 21, 2014 | 18:41PM EST
  23. Apple Stock Held By Institutional Investors Rises

    IBD | Aug. 21, 2014 | 17:02PM EST
  24. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus | Aug. 15, 2014 | 12:18PM EST
  25. Robert Wood Johnson's New Industry Made Surgery Safer

    IBD | Aug. 14, 2014 | 13:57PM EST
  26. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga | Aug. 12, 2014 | 16:53PM EST
  27. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD | Aug. 12, 2014 | 10:48AM EST
  28. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD | Aug. 8, 2014 | 11:55AM EST
  29. 3 Companies That Should Benefit From The New Initiative In Africa

    Benzinga | Aug. 7, 2014 | 09:40AM EST
  30. #PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of Banned Goods

    Benzinga | Aug. 7, 2014 | 07:03AM EST
  31. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus | Aug. 6, 2014 | 11:55AM EST
  32. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus | Aug. 5, 2014 | 11:56AM EST
  33. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD | Aug. 4, 2014 | 10:56AM EST
  34. Why Procter & Gamble Surged Higher On Friday?

    GuruFocus | Aug. 3, 2014 | 09:51AM EST
  35. Outlook for August 2014

    GuruFocus | Aug. 1, 2014 | 18:48PM EST
  36. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD | Aug. 1, 2014 | 12:35PM EST
  37. Unique 3D Startups And The Public Companies That Should Buy Them

    Benzinga | Aug. 1, 2014 | 10:31AM EST
  38. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD | Jul. 30, 2014 | 19:01PM EST
  39. Limiting Risk: A Little Exposure To High Yield Goes A Long Way

    GuruFocus | Jul. 29, 2014 | 18:54PM EST
  40. What's the Right PE Ratio?

    GuruFocus | Jul. 29, 2014 | 10:06AM EST
  41. Omnicom Tops Forecasts Despite Failed Publicis Merger

    IBD | Jul. 28, 2014 | 18:03PM EST
  42. BlackRock: Stocks Iffy, But Not These Pockets

    YCharts | Jul. 24, 2014 | 23:42PM EST
  43. YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation

    Benzinga | Jul. 24, 2014 | 16:16PM EST
  44. Just Post-It: 3M Is a Good Bet for Your Portfolio Today

    GuruFocus | Jul. 24, 2014 | 11:49AM EST
  45. Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit

    Benzinga | Jul. 24, 2014 | 09:32AM EST
  46. ...

    GuruFocus | Jul. 23, 2014 | 12:00PM EST
  47. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD | Jul. 22, 2014 | 12:42PM EST
  48. The 10 Most-Respected Corporate Brands

    Benzinga | Jul. 22, 2014 | 10:18AM EST
  49. Stocks To Watch For July 22, 2014

    Benzinga | Jul. 22, 2014 | 04:12AM EST
  50. Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?

    Benzinga | Jul. 18, 2014 | 16:12PM EST
Trading Center